Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Article Title: Immune activation throughout a boosted darunavir monotherapy simplification strategy.
doi: 10.1111/1469-0691.12521
Figure Lengend Snippet: FIG. 2. Evolution of sCD14 (a) and D-dimer (b) levels as a function of virological outcome during 24 months of ritonavir-boosted darunavir
Article Snippet: Moreover, sCD14 levels (Human sCD14 Quantikine ELISA; R&D Systems, Abingdon, UK) and plasma D-dimer levels (Human D-Dimer ELISA Kit; CUSABIO, Wuhan, China) were quantified by the use of ELISA-based assays, following the manufacturer’s recommendations, at baseline and after 24 months of mtDRV/rtv.
Techniques: